Potentiation of Cetuximab by Tregs Depletion With Metronomic Cyclophosphamide in Metastatic Squamous Cell Cancers of Head and Neck
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2015
At a glance
- Drugs Cetuximab (Primary) ; Cyclophosphamide
- Indications Head and neck cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 15 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Apr 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.